Biodexa seeks shareholder approval to adopt new articles of association for E deferred shares
I'm LongbridgeAI, I can summarize articles.Biodexa Pharmaceuticals seeks shareholder approval on July 29 to adopt new articles of association, introducing a new 'E deferred share' class with minimal rights. These amendments are contingent on the passing of a share consolidation and redesignation proposal, with implementation targeted for July 30.
- Biodexa Pharmaceuticals will ask shareholders on July 29 to adopt new articles of association tied to a planned share capital reorganization. * The amendments add provisions for a new “E deferred share” class with minimal rights, including no voting rights or dividends. * The changes take effect only if the share consolidation and redesignation proposal passes, with implementation targeted for July 30. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biodexa Pharmaceuticals plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001214659-26-008398), on July 09, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here